Table 2.

Patient Characteristics and Cytokine Genotypes With the Development of GVHD Grades III-IV

UPN Diagnosis CR HLA Type TNF − 308IL-10 Genotype TNFd Genotype GVHD OccurrenceSurvival Posttransplant (mo) Cause of Death
39 CGL  Cy/TBI  A2 A9 (24) B7 Bw22 (55) Cw3  F1/F1 i13/13* d3/d3 III  152  
40  AML  M/TBI  A2 A30 (19) B13 B39 (16) DR17 DR8  F1/F1  i9/13* d3/d3 III 25  
41  ALL  M/TBI  A28 A30 (19) B27 B44 (12) DR1501-1503 DR0701  F1/F1  i11/13* d3/d3 III  12 
42  CGL  Bu/M  A1 A11 B5 B57 (17) DR4 DR71 (3)  F1/F1 i12/12* d4/d4  III  2  Fungal infection  
43 AML  M/TBI  A25 A31 B18 B40 DR2 DR4  F1/F1  i8/15* d3/d3 III  1  Allotoxicity  
44  CGL Cy/TBI  A2 A3 B8 B5 DR3 DR5  F1/F2  i8/13* d1/d3 III  2  GVHD and viral infection  
45  AML M/TBI  A2 A3 B7 DR2 DR4  F1/F1  9/14* d3/d3 III 59  
46  ALL  Cy/TBI  A1 A3 B17 B15 DR4 DR7  F1/F1 i9/9  d4/d4  III  107  
47  AML  M/TBI  A1 A3 B8 B35 DR1 DR17 (3)  F1/F2  i9/13* d1/d4  III  122 Nontransplant?? related death  
48  MDS  Bu/Cy  A11 A32 B7 B4 DR4 DR7  F1/F1  i9/9  d3/d3 IV  GVHD  
49  AML  M/TBI  A2 A29 (19) B44 (12) DR4 DR7 F1/F1  i10/13* d3/d3 IV  2  VOD 
UPN Diagnosis CR HLA Type TNF − 308IL-10 Genotype TNFd Genotype GVHD OccurrenceSurvival Posttransplant (mo) Cause of Death
39 CGL  Cy/TBI  A2 A9 (24) B7 Bw22 (55) Cw3  F1/F1 i13/13* d3/d3 III  152  
40  AML  M/TBI  A2 A30 (19) B13 B39 (16) DR17 DR8  F1/F1  i9/13* d3/d3 III 25  
41  ALL  M/TBI  A28 A30 (19) B27 B44 (12) DR1501-1503 DR0701  F1/F1  i11/13* d3/d3 III  12 
42  CGL  Bu/M  A1 A11 B5 B57 (17) DR4 DR71 (3)  F1/F1 i12/12* d4/d4  III  2  Fungal infection  
43 AML  M/TBI  A25 A31 B18 B40 DR2 DR4  F1/F1  i8/15* d3/d3 III  1  Allotoxicity  
44  CGL Cy/TBI  A2 A3 B8 B5 DR3 DR5  F1/F2  i8/13* d1/d3 III  2  GVHD and viral infection  
45  AML M/TBI  A2 A3 B7 DR2 DR4  F1/F1  9/14* d3/d3 III 59  
46  ALL  Cy/TBI  A1 A3 B17 B15 DR4 DR7  F1/F1 i9/9  d4/d4  III  107  
47  AML  M/TBI  A1 A3 B8 B35 DR1 DR17 (3)  F1/F2  i9/13* d1/d4  III  122 Nontransplant?? related death  
48  MDS  Bu/Cy  A11 A32 B7 B4 DR4 DR7  F1/F1  i9/9  d3/d3 IV  GVHD  
49  AML  M/TBI  A2 A29 (19) B44 (12) DR4 DR7 F1/F1  i10/13* d3/d3 IV  2  VOD 

Characteristics and results on patients with grade III-IV GVHD showing unique patient number (UPN), diagnosis, conditioning regimes available HLA typing results, genotype for the TNF 308, IL-10 −1064, and TNFd microsatellite polymorphisms, occurrence of acute GVHD, survival, and cause of death.

Abbreviations: VOD, veno-occlusive disease; Cy/TBI, cyclophosphamide/TBI; M/TBI, melphalan/TBI. C/Bu, Busulphan; M/VP16/B, melphalan/atoposide/BCNU.

*

Patients who possessed an IL-10 microsatellite allele with greater numbers of dinucleotide repeats (alleles 12-15).

Patients who were homozygous for the TNFd3 allele (d3/d3).

Close Modal

or Create an Account

Close Modal
Close Modal